Kura Oncology (KURA) announced that an abstract containing preclinical data for KO-2806, the Company’s next-generation farnesyl transferase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback